Royalty Pharma plc Class A Ordinary Shares vs Smurfit WestRock plc Ordinary Shares — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Smurfit WestRock plc Ordinary Shares trades at $41.51 (market cap $21.66B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Smurfit WestRock plc Ordinary Shares pays the higher dividend (4.38%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Smurfit WestRock plc Ordinary Shares for 0 Days on average.
| RPRX | SW | |
|---|---|---|
Market Cap | $25.27B | $21.66B |
Volume | 3,671,183 | 3,627,328 |
Sector | Health | Consumer Cyclical |
52-Week High | $63.96 | $51.84 |
52-Week Low | $35.44 | $32.79 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $32.50B | $35.14B |
Dividend Yield | 1.66% | 4.38% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →Smurfit WestRock plc is an Ireland-headquartered packaging company that manufactures corrugated containers and consumer packaging from containerboard and paperboard, operating mills, converting plants, and recycling facilities across more than 40 countries.
Read more on SW →